Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001183740-07-000434
Filing Date
2007-07-03
Accepted
2007-07-03 18:35:29
Documents
1
Period of Report
2007-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2872
  Complete submission text file 0001183740-07-000434.txt   4837
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 NE JULEP STREET ISSAQUAH WA 98029
Business Address 425-996-8532
WILSON GLYNN (Reporting) CIK: 0001405625 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27239 | Film No.: 07962773